Shire’s drug Vyvanse became the first drug approved for sale in the U.S. to treat the estimated 2.8 million adults who have a binge-eating disorder.
WSJ.com: Europe Home, Wall Street Journal: World: Home Europe
Fri, 01/30/2015 - 4:20pm
Shire’s drug Vyvanse became the first drug approved for sale in the U.S. to treat the estimated 2.8 million adults who have a binge-eating disorder.